drugset / Trial / NCT06141200

NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial

NCT06141200

Phase 3 Unknown 286 enrolled Natural Wellness Egypt
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this Phase III clinical trial, researchers evaluate the efficacy and safety of NW Roselle®, a powdered medicinal product developed by Natural Wellness. NW Roselle combines extracts from Hibiscus Sabdariffa (HS) flowers and Olea europaea (OE) leaves. The trial aims to gather evidence on the efficacy and safety of NW Roselle as a potential treatment option for Grade 1 essential hypertension.

Timeline

Start
2024-03
Primary completion
2025-04
Completion
2025-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Captopril Small molecule 25 mg Oral
Subject NW Roselle Unknown 1000 mg Oral